Merck Investors Fight For American Pipe Tolling At 3rd Circ.
A group of institutional funds on Monday urged the Third Circuit to affirm that the so-called American Pipe tolling standard preserves their misrepresentation claims over Merck's Vytorin because their claims were...To view the full article, register now.
Already a subscriber? Click here to view full article